Clinical Trial Startup: Insights from the Industry
The clinical trial startup process has seen significant shifts over the past five years: growth in decentralized trials, improved technology,
The clinical trial startup process has seen significant shifts over the past five years: growth in decentralized trials, improved technology,
This case study covers a biotech company that partnered with Advarra, seeking to create a risk-based and proactive quality management system (QMS) to strengthen their service offering.
When it comes to clinical development, precision, compliance, and quality assurance are paramount. Like any complex and highly regulated industry,
HRPP staffing is essential for maintaining research ethics, even with sIRB mandates streamlining review processes for multisite studies. Discover key HRPP roles and benefits.
A mid-size clinical research and development (R&D) device company conducted studies in complex therapeutic areas without a clinical trial infrastructure in place to maintain required good clinical practices (GCP). Learn more about what Advarra put in place to help this organization improve its global GCPs, compliant clinical trial infrastructure, and quality framework in this case study.
GxP guidelines help clinical research meet rigorous standards for safety, quality, and compliance, supporting the development of therapies and medical devices.
Human research protection programs (HRPPs) play a critical role in protecting the rights, safety, and welfare of research participants. A
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
As research institutions are designing studies and recruiting participants for them, they must maintain compliance and ensure their study is
The clinical research industry is only becoming more complex and competitive as organizations are inundated with multiple trials and tight
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
An inspection readiness program can assess compliance, address deficiencies, and prepare sponsors and CROs for potential FDA inspections.